Phase 2 Trial of Atezolizumab in Bacillus Calmette-Guérin–unresponsive High-risk Non–muscle-invasive Bladder Cancer: SWOG S1605
暂无分享,去创建一个
W. Lowrance | I. Thompson | C. Tangen | M. Lucia | D. McConkey | S. Lerner | S. Porten | Parminder Singh | V. Koshkin | W. Kassouf | K. Stratton | R. Bangs | M. Plets | T. Bivalacqua | P. Black